# US 2013/0157335 A1 · Biomemory device comprising heterolayer of recombinant protein and inorganic particle

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157335 A1
- Document ID: US20130157335A1
- Status: Published application
- Kind: A1
- Application number: 13/564,136
- Filed: 2012-08-01
- Published: 2013-06-20
- Earliest claimed: 2011-12-16
- Assignees: Industry-University Cooperation Foundation Sogang University
- Inventors: Jeong Woo Choi; Taek Lee; Jun Hong Min
- Web page: https://patentgrep.com/patent/US20130157335A1

## CPC

- C07K 17/14: Peptides being immobilised on, or in, an inorganic carrier
- B82Y 10/00: Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
- C12N 11/14: Enzymes or microbial cells immobilised on or in an inorganic carrier
- G11C 13/0019: {comprising bio-molecules}
- B82Y 15/00: Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G11C: STATIC STORES (semiconductor memory devices H10B)

## Abstract

The present invention relates to a biomemory device, comprising (a) a substrate; and (b) a heterolayer comprising a protein having a redox potential and an inorganic particle; wherein the heterolayer is immobilized on the substrate. By applying inorganic particles, the present invention provides a biomemory device capable of enhancing low current signals detected electron transfer between biomolecules and substrates up to at least five (5) times greater signals. The present invention is capable of controlling the redox states with help of redox potentials of proteins depending on applied potential. The present invention provides a new-concept biomemory device as an information storage device based on the principle of electron transfer of a naturally occurring biomolecule.

## Claims

### Claim 1

A biomemory device, comprising (a) a substrate; and (b) a heterolayer comprising a protein having a redox potential and an inorganic particle; wherein the heterolayer is immobilized on the substrate.

### Claim 2 (depends on 1)

The biomemory device according to claim 1, wherein the protein having a redox potential is a recombinant protein and is directly immobilized on the substrate via a cysteine residue introduced to the recombinant protein.

### Claim 3 (depends on 1)

The biomemory device according to claim 1, wherein the protein is a metalloprotein.

### Claim 4 (depends on 3)

The biomemory device according to claim 3, wherein the metalloprotein is azurin, hemoglobin, myoglobin, hemerythrin, cytochrome, iron-sulfur protein, rubredoxin, plastocyanin, ferritin, ceruloplasmin, carbonic anhydrase, vitamin B12-dependent enzyme, nitrogenase, superoxide dismutase, chlorophyll-containing protein, calmodulin, glucose 6-phosphatase, hexokinase, DNA polymerase, vanabin, arginase, catalase, hydrogenase, iron-responsive element-binding protein, aconitase, urease, cytochrome oxidase, laccase, alcohol dehydrogenase, carboxypeptidase, aminopeptidase, β-amyloid, nitrate reductase, glutathione peroxidase, metallothionein or phosphatase.

### Claim 5 (depends on 4)

The biomemory device according to claim 4, wherein the metalloprotein is azurin.

### Claim 6 (depends on 1)

The biomemory device according to claim 1, wherein the inorganic particle is a metal particle, a metal oxide particle, an alloy particle or a semiconductor particle.

### Claim 7 (depends on 6)

The biomemory device according to claim 6, wherein the inorganic particle is a metal particle.

### Claim 8 (depends on 7)

The biomemory device according to claim 7, wherein the metal particle is a gold (Au) particle.

### Claim 9 (depends on 8)

The biomemory device according to claim 8, wherein the gold (Au) particle is 1-100 nm in size.

### Claim 10 (depends on 1)

The biomemory device according to claim 1, wherein the heterolayer is immobilized on the substrate via the protein.

### Claim 11 (depends on 1)

The biomemory device according to claim 1, wherein the inorganic particle is covalently bonded to the protein and is indirectly immobilized on the substrate via the protein.

### Claim 12 (depends on 1)

The biomemory device according to claim 1, wherein the substrate is a metal, metal oxide, glass, ceramic, quartz, silicon, semiconductor, Si/SiO2 wafer, germanium, gallium arsenide, carbon, carbon nanotube, polymer, sepharose or agarose substrate.

### Claim 13 (depends on 10)

The biomemory device according to claim 10, wherein the substrate is a gold (Au) substrate.

### Claim 14 (depends on 1)

The biomemory device according to claim 1, wherein the biomemory device is operated by applying a reduction potential and an oxidation potential.
